Clinical Trial

Optimal Timing for Laparoscopic Cholecystectomy After Cholecystostomy in Acute Cholecystitis Tokyo II/III Setting

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 28, 2024 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Percutaneous drainage in acute cholecystitis has been recommended by the recent update of the Tokyo Guidelines for patients with grade II and III disease who are unable to undergo surgical treatment due to their condition or associated comorbidities. There are no reports providing high-quality scientific evidence on the optimal timing for surgery after percutaneous transhepatic gallbladder drainage, so a consensus has not been reached. The grade III stage generates the most controversy; after percutaneous drainage, delaying the cholecystectomy can lead to new episodes of exacerbation during the waiting period or may limit the procedure to a specific group of patients with this pathology. The economic impact, including the number of readmissions, increased length of stay, and associated morbidity and mortality, generates controversy regarding the subsequent therapeutic decisions after the medical management of cholecystitis in this special group of patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-19.
Trial Details
NCT Number NCT06476054
Lead Sponsor Hospital Arnau de Vilanova
Conditions Cholecystitis, Acute
Enrollment 146 participants
Start Date 2024-02-01
Primary Completion 2026-08-01 (estimated)
Study Completion 2027-08-01 (estimated)
Updated on ClinicalTrials.gov 2024-06-28